Master Guide: Clinical Biochemistry and Urinalysis in Veterinary Medicine
Introduction: Historical Context and Foundational Principles
Clinical biochemistry and urinalysis represent the cornerstone of laboratory medicine in veterinary practice, offering a window into the metabolic, functional, and pathological status of animal patients. The historical development of these disciplines traces back to the mid-19th century, when pioneering physiologists such as Claude Bernard began systematically analyzing blood and urine constituents to understand organ function. The advent of colorimetric assays in the early 20th century, followed by the development of automated analyzers in the 1960s and 1970s, revolutionized veterinary diagnostics by enabling rapid, reproducible, and quantitative assessment of multiple analytes simultaneously.
The fundamental chemical principles underlying clinical biochemistry rely on the measurement of specific molecules-substrates, enzymes, electrolytes, and hormones-through reactions that produce detectable signals. These reactions typically exploit enzyme-substrate interactions, antibody-antigen binding, or chemical chromogen formation. Spectrophotometry, the most common detection method, measures light absorption at specific wavelengths, with the degree of absorption proportional to analyte concentration according to the Beer-Lambert law. Ion-selective electrodes, used for electrolyte measurement, detect electrical potential differences generated by specific ions across a semipermeable membrane. Enzymatic assays, such as those for alanine aminotransferase (ALT) or alkaline phosphatase (ALP), measure catalytic activity rather than absolute concentration, providing functional insight into tissue integrity.
Urinalysis, in contrast, combines physical, chemical, and microscopic examination to evaluate renal function and detect systemic disease. The physical principles involve assessment of color, turbidity, specific gravity (refractometry), and osmolality. Chemical analysis employs dipstick technology, where reagent pads impregnated with specific chemicals undergo color changes in the presence of analytes such as glucose, protein, ketones, bilirubin, urobilinogen, nitrite, and blood. Microscopic examination of urine sediment, following centrifugation, allows identification of cells, casts, crystals, and microorganisms.
Laboratory Protocols, Controls, and Quality Assurance
Preanalytical Considerations
The reliability of clinical biochemistry and urinalysis begins with meticulous preanalytical management. Blood collection must be performed using appropriate venipuncture techniques, with minimal hemolysis, as hemolyzed samples falsely elevate potassium, phosphate, and AST activities while interfering with spectrophotometric measurements. Fasting status is critical for accurate glucose, triglyceride, and bile acid measurements; a 12-hour fast is standard for most species, though exceptions exist for neonates and certain metabolic studies. Anticoagulant selection is equally important: heparinized plasma is preferred for many biochemical assays, while serum is required for protein electrophoresis and certain hormone analyses. EDTA, while excellent for hematology, chelates calcium and inhibits many enzyme reactions, rendering it unsuitable for most biochemistry panels.
Sample handling and storage profoundly affect analyte stability. Whole blood should be centrifuged within 30 minutes of collection to separate plasma or serum. Refrigeration at 4 degrees C preserves most analytes for 24-48 hours, while freezing at −20 degrees C or −80 degrees C is required for longer storage, particularly for hormones, bile acids, and ammonia. Repeated freeze-thaw cycles must be avoided, as they denature proteins and degrade labile analytes.
Analytical Protocols
Modern veterinary biochemistry analyzers operate on either wet chemistry or dry chemistry principles. Wet chemistry systems mix liquid reagents with sample in cuvettes, allowing precise temperature control and reaction monitoring. Dry chemistry systems, such as the IDEXX Catalyst or Abaxis Vetscan, use reagent-impregnated slides or rotors that require minimal sample volume and are particularly suited for in-clinic use. Both systems employ internal calibrators and controls to ensure accuracy.
Quality assurance programs encompass three levels: internal quality control (IQC), external quality assessment (EQA), and proficiency testing. IQC involves running commercial control materials with known concentrations at defined intervals-typically at the beginning of each run, after calibration, and whenever reagent lots change. Levey-Jennings charts track control values over time, allowing detection of systematic errors through Westgard rules. EQA programs, such as those offered by the Veterinary Laboratory Association or the Royal College of Pathologists, provide interlaboratory comparison, identifying calibration drift or method-specific biases.
Postanalytical Interpretation
Reference intervals must be species-specific, age-specific, and ideally breed-specific, as significant variations exist. For example, Greyhounds have physiologically lower serum creatinine and higher hematocrit than other breeds, while young animals have higher ALP activity due to bone growth. Interpretation requires integration of multiple analytes into patterns-a single abnormal value rarely provides a diagnosis, but constellations of abnormalities point toward specific organ system dysfunction.
Comparative Diagnostic Utility: Sensitivity, Specificity, and Cost-Effectiveness
Clinical biochemistry and urinalysis occupy a unique niche in the diagnostic armamentarium, offering moderate sensitivity and specificity for organ system dysfunction but limited etiological specificity. Compared to molecular diagnostics such as polymerase chain reaction (PCR), which can detect minute quantities of pathogen DNA or RNA with near-perfect sensitivity and specificity, biochemistry provides functional rather than etiological information. For example, elevated liver enzymes indicate hepatocellular injury or cholestasis but cannot distinguish between viral hepatitis, bacterial cholangitis, or toxin exposure.
Serological assays, including ELISA and virus neutralization tests, offer higher specificity for infectious diseases by detecting pathogen-specific antibodies or antigens. However, serology cannot differentiate active infection from prior exposure or vaccination, a limitation that biochemistry does not share. Hematology, while complementary, provides information primarily about cellular elements of blood rather than metabolic function.
The cost-effectiveness of biochemistry and urinalysis is exceptional. A comprehensive biochemistry panel costs approximately $50-150, while urinalysis adds $20-50, making these tests accessible for routine screening and monitoring. In contrast, PCR assays for individual pathogens cost $50-200 each, and advanced imaging such as MRI or CT scans costs $500-2,000. For initial evaluation of sick animals, biochemistry and urinalysis provide the highest diagnostic yield per dollar spent, often guiding more expensive or specialized testing.
Major Applications in Veterinary Medicine
Metabolic and Endocrine Disease
Clinical biochemistry is indispensable for diagnosing metabolic disorders. Diabetes mellitus is identified by persistent hyperglycemia (glucose >180 mg/dL in dogs, >200 mg/dL in cats) with glucosuria, though stress hyperglycemia in cats requires caution. Fructosamine measurement provides a 2-3 week glycemic history, distinguishing stress from true diabetes. Hyperadrenocorticism (Cushing's syndrome) is suggested by elevated ALP, cholesterol, and glucose, with confirmatory testing via ACTH stimulation or low-dose dexamethasone suppression. Hypoadrenocorticism (Addison's disease) presents with hyponatremia, hyperkalemia, and a sodium-to-potassium ratio below 27:1, though normal electrolytes do not rule out atypical forms.
Renal Disease
Urinalysis is the first-line test for renal disease. Proteinuria, detected by dipstick or quantified via urine protein-to-creatinine ratio (UPC), indicates glomerular or tubular damage. Casts-hyaline, granular, or cellular-localize pathology to the renal tubules. Specific gravity measurement assesses concentrating ability; isosthenuria (SG 1.008-1.012) in a dehydrated animal indicates renal failure. Serum biochemistry reveals azotemia (elevated BUN and creatinine), though creatinine is more specific for glomerular filtration rate. Symmetric dimethylarginine (SDMA) is a more sensitive early marker, detecting renal dysfunction when creatinine is still within reference intervals.
Hepatic Disease
Liver enzyme activities provide pattern recognition for hepatobiliary disease. ALT and AST elevation indicates hepatocellular injury, with ALT being more liver-specific in dogs and cats. ALP and gamma-glutamyltransferase (GGT) elevation suggests cholestasis, though ALP is induced by corticosteroids and certain drugs. Bilirubin measurement differentiates prehepatic (hemolytic), hepatic, and posthepatic (obstructive) jaundice. Bile acid stimulation testing assesses hepatic function and portosystemic shunting, with fasting and postprandial samples required.
Pancreatic Disease
Pancreatitis, common in dogs and cats, is diagnosed through serum lipase and pancreatic lipase immunoreactivity (PLI). Canine pancreatic lipase immunoreactivity (cPLI) and feline pancreatic lipase immunoreactivity (fPLI) are species-specific assays with high sensitivity and specificity. Amylase is less reliable due to extra-pancreatic sources. Urinalysis may reveal glucosuria in severe cases with concurrent diabetes.
Infectious Diseases
While biochemistry and urinalysis cannot identify specific pathogens, they provide critical supportive evidence and guide further testing. In viral infections such as canine parvovirus, biochemistry reveals panleukopenia (though this is a hematological finding), electrolyte disturbances from vomiting and diarrhea, and elevated liver enzymes from systemic inflammation. Feline infectious peritonitis (FIP) is associated with hyperglobulinemia, particularly an elevated gamma globulin fraction on protein electrophoresis, and a low albumin-to-globulin ratio (<0.6). Leptospirosis, a bacterial zoonosis, causes acute renal and hepatic failure, with azotemia, elevated liver enzymes, and bilirubinuria. Urinalysis may demonstrate proteinuria, hematuria, and pyuria, though organisms are rarely visualized.
Bacterial urinary tract infections are diagnosed through urinalysis, with pyuria, bacteriuria, and positive nitrite (though less sensitive in dogs and cats than humans). Urine culture and sensitivity confirm the diagnosis and guide antimicrobial therapy. In chronic kidney disease, urinalysis may reveal isosthenuria, proteinuria, and active sediment, while biochemistry shows progressive azotemia and hyperphosphatemia.
Musculoskeletal and Cardiac Disease
Creatine kinase (CK) and aspartate aminotransferase (AST) elevation indicates muscle injury, with CK being more specific. Cardiac troponin I (cTnI) is a sensitive marker for myocardial injury, elevated in dilated cardiomyopathy, myocardial infarction, and severe systemic inflammation. Urinalysis is less directly relevant but may show myoglobinuria in severe rhabdomyolysis.
Limitations and Pitfalls
Despite its utility, clinical biochemistry and urinalysis have inherent limitations. Reference intervals are population-based and may not apply to individual animals, particularly those with extreme age, breed, or physiological status. Many analytes have diurnal variation, and stress from sampling can alter results-cortisol, glucose, and ALP are particularly labile. Drug interferences are common: corticosteroids induce ALP, phenobarbital elevates liver enzymes, and furosemide causes electrolyte disturbances.
False-positive and false-negative results occur with dipstick urinalysis. For example, highly alkaline urine (pH >8) can produce false-positive protein readings, while dilute urine may mask glucosuria or proteinuria. Microscopic examination requires expertise, as artifacts such as starch granules or air bubbles can be mistaken for crystals or cells.
Conclusion
Clinical biochemistry and urinalysis remain essential tools in veterinary diagnostics, providing rapid, cost-effective, and functional assessment of organ systems. Their strength lies not in etiological specificity but in pattern recognition, guiding clinicians toward appropriate differential diagnoses and targeted testing. When integrated with history, physical examination, and other laboratory modalities, these tests form the foundation of evidence-based veterinary medicine.
References
- Kaneko JJ, Harvey JW, Bruss ML. Clinical Biochemistry of Domestic Animals. 6th ed. Academic Press; 2008.
- Stockham SL, Scott MA. Fundamentals of Veterinary Clinical Pathology. 2nd ed. Blackwell Publishing; 2008.
- Thrall MA, Weiser G, Allison RW, Campbell TW. Veterinary Hematology and Clinical Chemistry. 2nd ed. Wiley-Blackwell; 2012.
- Willard MD, Tvedten H. Small Animal Clinical Diagnosis by Laboratory Methods. 5th ed. Saunders; 2012.
- MacWilliams PS, Friedrichs KR. Laboratory Medicine: Urinalysis and Clinical Biochemistry. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 8th ed. Elsevier; 2017.
- Fenner FJ, Bachmann PA, Gibbs EPJ, et al. Fenner's Veterinary Virology. 5th ed. Academic Press; 2016.
- Greene CE. Infectious Diseases of the Dog and Cat. 4th ed. Saunders; 2012.
- Nelson RW, Couto CG. Small Animal Internal Medicine. 5th ed. Mosby; 2014.
- Bush BM. Interpretation of Laboratory Results for Small Animal Clinicians. Blackwell Scientific Publications; 1991.
- Duncan JR, Prasse KW, Mahaffey EA. Veterinary Laboratory Medicine: Clinical Pathology. 3rd ed. Iowa State University Press; 1994.